- Home
- Industry Reports
- Healthcare
- Medical Devices
- Global Point of Care Diagnostics Market – Size, Outlook, Trends and Forecast (2023 – 2030)
Point-of-care testing (POCT) is essential for the rapid detection of analytes near to the patient, which facilitates better disease diagnosis, monitoring, and management. It enables quick medical decisions, as the diseases can be diagnosed at a very early stage, leading to improved health outcomes for patients by enabling the early start of treatment. The global Point-of-Care Diagnostics market was valued at $21.40 Billion in 2016 and is expected to reach $45.87 Billion by 2022, at a CAGR of 10.0% during the forecast period. Increase in incidence of target diseases and technological advancements and new product launches are the drivers that boost the growth of the market. On the flipside, the high cost of devices and Lack of knowledge on the usage on POC devices are the restraints that hamper the market growth. Increase in POC tests with multiplexing capabilities and a rise in emerging markets are the opportunities for the market.
Research Study Objectives:
- Define, estimate, and forecast the Point of Care Diagnostics market statistics by platform, product, prescription mode, end user and regions concerning the individual growth drivers, market trends and their contribution toward the Point of Care Diagnostics market growth
- Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints & Challenges, and Opportunities)
- Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).
- Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the Point of Care Diagnostics Market Analysis
- Analysis and conclusions on the future Point of Care Diagnostics market outlook.
Top-down and bottom-up approaches are used to validate the Point of Care Diagnostics Market Size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The Point of Care Diagnostics Market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the Point of Care Diagnostics market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.
The scope of the Report
The Point of Care Diagnostics market segmentation is as follows:
By Product
- Tumor/Cancer Marker Testing Products
- Urinalysis Testing Products
- Cholesterol Testing Products
- Hematology Testing Products
- Drugs-of-Abuse Testing Products
- Fecal Occult Testing Products
- Cardiometabolic Testing Products
- Glucose Monitoring Products
- Infectious Disease Testing Products
- Coagulation Testing Products
- Pregnancy and Fertility Testing Products
By Prescription Mode
- Prescription-Based Testing
- OTC Testing
By Platform
- Molecular Diagnostics
- Dipsticks
- Microfluidics
- Lateral Flow Assays
- Immunoassays
By End Users
- Professional Diagnostic Centres
- Home Care
- Research Laboratories
- Other End Users
Geographical Analysis:
Point of Care Diagnostics Market is segmented by geography into North America, South America, Europe, APAC and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.
Customization Options:
With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the Point of Care Diagnostics Market include:
- Scope Revision
- Geographic Analysis
- Company Profiles
- Historical Data & Forecasting
- Key Contact Persons in companies
Global Point of Care Diagnostics Market Research Report Includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOTanalysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
- Identifying DROC in the current market and their impact on altering market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the significant Point of Care Diagnostics market players, such as
- Trinity Biotech
- PTS Diagnostics
- Becton, Dickinson, and Company (BD)
- EKF Diagnostics
- Johnson & Johnson
- Along with these companies, many other companies are considered in the report while analysing the Global Point of Care Diagnostics competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.
CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter’s Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increase in incidence of target diseases
4.1.2. Growing usage of home-based POC devices
4.1.3. Technological advancements and new product launches
4.1.4. Rise in infectious diseases in developing countries
4.2. Market Restraints & Challenges
4.2.1. The high cost of devices
4.2.2. Lack of knowledge on the usage on POC devices
4.3.3. Stringent and time-consuming policies
4.3. Market Opportunities
4.3.1. The rise in emerging markets
4.3.2. Increase in POC tests with multiplexing capabilities
CHAPTER 5. GLOBAL POINT OF CARE DIAGNOSTICS MARKET– BY
PLATFORM
5.1 Introduction
5.2 Molecular Diagnostics
5.3 Dipsticks
5.4 Microfluidics
5.5 Lateral Flow Assays
5.6 Immunoassays
CHAPTER 6. GLOBAL POINT OF CARE DIAGNOSTICS MARKET– BY PRODUCT
6.1. Introduction
6.2. Tumour/Cancer Marker Testing Products
6.3. Urinalysis Testing Products
6.4. Cholesterol Testing Products
6.5. Haematology Testing Products
6.6. Drugs-of-Abuse Testing Products
6.7. Faecal Occult Testing Products
6.8. Other POC Products
6.9. Cardiometabolic Testing Products
6.9.1 Cardiac Marker Testing Products
6.9.2 Blood Gas/Electrolytes Testing Products
6.9.3 HBA1C Testing Products
6.10. Glucose Monitoring Products
6.10.1 Strips
6.10.2 Meters
6.10.3 Lancets & Lancing Devices
6.11. Infectious Disease Testing Products
6.11.1. Influenza Testing Products
6.11.2. HIV Testing Products
6.11.3. Hepatitis C Testing Products
6.11.4. Sexually Transmitted Disease (STD) Testing Products
6.11.5. Healthcare-Associated Infection (HAI) Testing Products
6.11.6. Respiratory Infection Testing Products
6.11.7. Tropical Disease Testing Products
6.11.8. Other Infectious Disease Testing Products
6.12. Coagulation Testing Products
6.12.1.PT/INR Testing Products
6.12.2. Activated Clotting Time (ACT/APTT) Testing Products
6.13. Pregnancy and Fertility Testing Products
6.13.1. Pregnancy Testing Products
6.13.2. Fertility Testing Products
CHAPTER 7. GLOBAL POINT OF CARE DIAGNOSTICS MARKET– BY
PRESCRIPTION MODE
7.1 Introduction
7.2 Prescription-Based Testing
7.3 OTC Testing
CHAPTER 8. GLOBAL POINT OF CARE DIAGNOSTICS MARKET– BY END USER
8.1. Introduction
8.2. Professional Diagnostic Centers
8.2.1. Outpatient Healthcare & Ambulatory Care Settings
8.2.2. Hospitals/Critical Care Centers
8.3. Home Care
8.4. Research Laboratories
8.5. Other End Users
CHAPTER 9. GLOBAL POINT OF CARE DIAGNOSTICS MARKET– BY
GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. APAC
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10. GLOBAL POINT OF CARE DIAGNOSTICS MARKET– COMPANY
PROFILES
10.1. Trinity Biotech
10.2. PTS Diagnostics
10.3. Becton, Dickinson, and Company (BD)
10.4. Chembio Diagnostics
10.5. Quidel Corporation
10.6. EKF Diagnostics
10.7. Abbott Laboratories
10.8. Johnson & Johnson
10.9. Nova Biomedical
10.10. Instrumentation Laboratory
10.11. Danaher Corporation
10.12. Roche Diagnostics
10.13. Sekisui Diagnostics
10.14. Siemens
10.15. AccuBiotech Co., Ltd.
CHAPTER 11. GLOBAL POINT OF CARE DIAGNOSTICS MARKET–
COMPETITIVE LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12. MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13. APPENDIX
13.1. List of Tables
13.2. List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Global Report
$2,700.00 – $8,100.00
- EUR: €2,508.59 - €7,525.78
- INR: ₹222,356.78 - ₹667,070.33
- AED: د.إ9,909.00 - د.إ29,727.00
- GBP: £2,155.64 - £6,466.91
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Point-of-care testing (POCT) is essential for the rapid detection of analytes near to the patient, which facilitates better disease diagnosis, monitoring, and management. It enables quick medical decisions, as the diseases can be diagnosed at a very early stage, leading to improved health outcomes for patients by enabling the early start of treatment. The global Point-of-Care Diagnostics market was valued at $21.40 Billion in 2016 and is expected to reach $45.87 Billion by 2022, at a CAGR of 10.0% during the forecast period. Increase in incidence of target diseases and technological advancements and new product launches are the drivers that boost the growth of the market. On the flipside, the high cost of devices and Lack of knowledge on the usage on POC devices are the restraints that hamper the market growth. Increase in POC tests with multiplexing capabilities and a rise in emerging markets are the opportunities for the market.
Research Study Objectives:
- Define, estimate, and forecast the Point of Care Diagnostics market statistics by platform, product, prescription mode, end user and regions concerning the individual growth drivers, market trends and their contribution toward the Point of Care Diagnostics market growth
- Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints & Challenges, and Opportunities)
- Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).
- Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the Point of Care Diagnostics Market Analysis
- Analysis and conclusions on the future Point of Care Diagnostics market outlook.
Top-down and bottom-up approaches are used to validate the Point of Care Diagnostics Market Size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The Point of Care Diagnostics Market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the Point of Care Diagnostics market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.
The scope of the Report
The Point of Care Diagnostics market segmentation is as follows:
By Product
- Tumor/Cancer Marker Testing Products
- Urinalysis Testing Products
- Cholesterol Testing Products
- Hematology Testing Products
- Drugs-of-Abuse Testing Products
- Fecal Occult Testing Products
- Cardiometabolic Testing Products
- Glucose Monitoring Products
- Infectious Disease Testing Products
- Coagulation Testing Products
- Pregnancy and Fertility Testing Products
By Prescription Mode
- Prescription-Based Testing
- OTC Testing
By Platform
- Molecular Diagnostics
- Dipsticks
- Microfluidics
- Lateral Flow Assays
- Immunoassays
By End Users
- Professional Diagnostic Centres
- Home Care
- Research Laboratories
- Other End Users
Geographical Analysis:
Point of Care Diagnostics Market is segmented by geography into North America, South America, Europe, APAC and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.
Customization Options:
With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the Point of Care Diagnostics Market include:
- Scope Revision
- Geographic Analysis
- Company Profiles
- Historical Data & Forecasting
- Key Contact Persons in companies
Global Point of Care Diagnostics Market Research Report Includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOTanalysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
- Identifying DROC in the current market and their impact on altering market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the significant Point of Care Diagnostics market players, such as
- Trinity Biotech
- PTS Diagnostics
- Becton, Dickinson, and Company (BD)
- EKF Diagnostics
- Johnson & Johnson
- Along with these companies, many other companies are considered in the report while analysing the Global Point of Care Diagnostics competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.
CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter’s Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increase in incidence of target diseases
4.1.2. Growing usage of home-based POC devices
4.1.3. Technological advancements and new product launches
4.1.4. Rise in infectious diseases in developing countries
4.2. Market Restraints & Challenges
4.2.1. The high cost of devices
4.2.2. Lack of knowledge on the usage on POC devices
4.3.3. Stringent and time-consuming policies
4.3. Market Opportunities
4.3.1. The rise in emerging markets
4.3.2. Increase in POC tests with multiplexing capabilities
CHAPTER 5. GLOBAL POINT OF CARE DIAGNOSTICS MARKET– BY
PLATFORM
5.1 Introduction
5.2 Molecular Diagnostics
5.3 Dipsticks
5.4 Microfluidics
5.5 Lateral Flow Assays
5.6 Immunoassays
CHAPTER 6. GLOBAL POINT OF CARE DIAGNOSTICS MARKET– BY PRODUCT
6.1. Introduction
6.2. Tumour/Cancer Marker Testing Products
6.3. Urinalysis Testing Products
6.4. Cholesterol Testing Products
6.5. Haematology Testing Products
6.6. Drugs-of-Abuse Testing Products
6.7. Faecal Occult Testing Products
6.8. Other POC Products
6.9. Cardiometabolic Testing Products
6.9.1 Cardiac Marker Testing Products
6.9.2 Blood Gas/Electrolytes Testing Products
6.9.3 HBA1C Testing Products
6.10. Glucose Monitoring Products
6.10.1 Strips
6.10.2 Meters
6.10.3 Lancets & Lancing Devices
6.11. Infectious Disease Testing Products
6.11.1. Influenza Testing Products
6.11.2. HIV Testing Products
6.11.3. Hepatitis C Testing Products
6.11.4. Sexually Transmitted Disease (STD) Testing Products
6.11.5. Healthcare-Associated Infection (HAI) Testing Products
6.11.6. Respiratory Infection Testing Products
6.11.7. Tropical Disease Testing Products
6.11.8. Other Infectious Disease Testing Products
6.12. Coagulation Testing Products
6.12.1.PT/INR Testing Products
6.12.2. Activated Clotting Time (ACT/APTT) Testing Products
6.13. Pregnancy and Fertility Testing Products
6.13.1. Pregnancy Testing Products
6.13.2. Fertility Testing Products
CHAPTER 7. GLOBAL POINT OF CARE DIAGNOSTICS MARKET– BY
PRESCRIPTION MODE
7.1 Introduction
7.2 Prescription-Based Testing
7.3 OTC Testing
CHAPTER 8. GLOBAL POINT OF CARE DIAGNOSTICS MARKET– BY END USER
8.1. Introduction
8.2. Professional Diagnostic Centers
8.2.1. Outpatient Healthcare & Ambulatory Care Settings
8.2.2. Hospitals/Critical Care Centers
8.3. Home Care
8.4. Research Laboratories
8.5. Other End Users
CHAPTER 9. GLOBAL POINT OF CARE DIAGNOSTICS MARKET– BY
GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. APAC
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10. GLOBAL POINT OF CARE DIAGNOSTICS MARKET– COMPANY
PROFILES
10.1. Trinity Biotech
10.2. PTS Diagnostics
10.3. Becton, Dickinson, and Company (BD)
10.4. Chembio Diagnostics
10.5. Quidel Corporation
10.6. EKF Diagnostics
10.7. Abbott Laboratories
10.8. Johnson & Johnson
10.9. Nova Biomedical
10.10. Instrumentation Laboratory
10.11. Danaher Corporation
10.12. Roche Diagnostics
10.13. Sekisui Diagnostics
10.14. Siemens
10.15. AccuBiotech Co., Ltd.
CHAPTER 11. GLOBAL POINT OF CARE DIAGNOSTICS MARKET–
COMPETITIVE LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12. MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13. APPENDIX
13.1. List of Tables
13.2. List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.